Ursodeoxycholic Acid API Market Forecasting Growth to $1.09 Billion by 2031- QY Research Inc. Releases In-Depth Market Report

Los Angeles, CA - QY Research Inc., a leading global market research publisher, has unveiled its latest market report, "Ursodeoxycholic Acid API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". This comprehensive study provides an in-depth analysis of the Ursodeoxycholic Acid (UDCA) API market, highlighting key industry trends, market size projections, competitive landscapes, and future growth opportunities.

According to the report, the global Ursodeoxycholic Acid API market was valued at USD 597 million in 2024 and is expected to reach USD 1.09 billion by 2031, growing at a CAGR of 9.0% during the forecast period from 2025 to 2031. The market is primarily driven by the increasing prevalence of liver diseases, growing medical awareness, and rising demand for effective treatments such as UDCA.

Download Sample Report Pages For Better understanding@ https://www.qyresearch.com/sample/4258411

The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) API market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA API as a key component in manufacturing medications to address these conditions.

However, the UDCA API market faces several challenges, with regulatory hurdles and price pressures being significant constraints. The stringent approval requirements and the need for high-quality production standards in API manufacturing can delay the market entry of new players and increase operational costs. Furthermore, with the increasing production of generic UDCA products, competition has intensified, leading to a decrease in profit margins for manufacturers of branded UDCA drugs. Another challenge is the limited scope of UDCA applications, as the drug is effective primarily for a specific set of liver conditions, limiting its broader market appeal. Additionally, supply chain disruptions and raw material price fluctuations for manufacturing UDCA can affect the availability and cost-effectiveness of APIs, further complicating market dynamics.

Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top four players hold a share about 60%. APAC is the largest market, has a share about 50%. In terms of product type, Synthetic UDCA is the largest segment, occupied for a share of about 98%, and in terms of application, Pharmacy has a share about 90 percent.

Competitive Landscape

According to QY Research, the top four players in the Ursodeoxycholic Acid API market-ICE, Daewoong Chemical, Dipharma Francis, and Zhongshan Bailing-account for approximately 63.0% of global revenue. The report provides a thorough competitive analysis, detailing the market positioning, production capacities, and revenue shares of key manufacturers.

Market Segmentation

By Type:

Synthetic UDCA (Largest segment, holding a 98.7% market share)
Extraction UDCA

By Application:

Pharmacy (Largest segment, with a 91.6% market share)
Health Products

By Region:

APAC (Largest consumer, with a 52.95% market share in 2024)
Europe (Second-largest consumer, with a 29.01% market share)

Strategic Insights & Industry Outlook

The report provides comprehensive insights into the UDCA API market, helping industry stakeholders identify profit opportunities, develop targeted marketing strategies, and optimize resource allocation. The findings indicate that APAC will continue to dominate the market, with Europe following as the second-largest consumer region. The continued demand for cost-effective and efficient treatments will drive innovation and competition among manufacturers.

For Further insights and Detailed Reports, Visit: https://www.qyresearch.com/customize/4258411

Table of Contents

1 Market Overview
1.1 Ursodeoxycholic Acid API Product Introduction
1.2 Global Ursodeoxycholic Acid API Market Size Forecast
1.2.1 Global Ursodeoxycholic Acid API Sales Value (2020-2031)
1.2.2 Global Ursodeoxycholic Acid API Sales Volume (2020-2031)
1.2.3 Global Ursodeoxycholic Acid API Sales Price (2020-2031)
1.3 Ursodeoxycholic Acid API Market Trends & Drivers
1.3.1 Ursodeoxycholic Acid API Industry Trends
1.3.2 Ursodeoxycholic Acid API Market Drivers & Opportunity
1.3.3 Ursodeoxycholic Acid API Market Challenges
1.3.4 Ursodeoxycholic Acid API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Ursodeoxycholic Acid API Players Revenue Ranking (2024)
2.2 Global Ursodeoxycholic Acid API Revenue by Company (2020-2025)
2.3 Global Ursodeoxycholic Acid API Players Sales Volume Ranking (2024)
2.4 Global Ursodeoxycholic Acid API Sales Volume by Company Players (2020-2025)
2.5 Global Ursodeoxycholic Acid API Average Price by Company (2020-2025)
2.6 Key Manufacturers Ursodeoxycholic Acid API Manufacturing Base and Headquarters
2.7 Key Manufacturers Ursodeoxycholic Acid API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ursodeoxycholic Acid API
2.9 Ursodeoxycholic Acid API Market Competitive Analysis
2.9.1 Ursodeoxycholic Acid API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ursodeoxycholic Acid API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ursodeoxycholic Acid API as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Synthetic UDCA
3.1.2 Extraction UDCA
3.2 Global Ursodeoxycholic Acid API Sales Value by Type
3.2.1 Global Ursodeoxycholic Acid API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ursodeoxycholic Acid API Sales Value, by Type (2020-2031)
3.2.3 Global Ursodeoxycholic Acid API Sales Value, by Type (%) (2020-2031)
3.3 Global Ursodeoxycholic Acid API Sales Volume by Type
3.3.1 Global Ursodeoxycholic Acid API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ursodeoxycholic Acid API Sales Volume, by Type (2020-2031)
3.3.3 Global Ursodeoxycholic Acid API Sales Volume, by Type (%) (2020-2031)
3.4 Global Ursodeoxycholic Acid API Average Price by Type (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy
4.1.2 Health Products
4.2 Global Ursodeoxycholic Acid API Sales Value by Application
4.2.1 Global Ursodeoxycholic Acid API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ursodeoxycholic Acid API Sales Value, by Application (2020-2031)
4.2.3 Global Ursodeoxycholic Acid API Sales Value, by Application (%) (2020-2031)
4.3 Global Ursodeoxycholic Acid API Sales Volume by Application
4.3.1 Global Ursodeoxycholic Acid API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ursodeoxycholic Acid API Sales Volume, by Application (2020-2031)
4.3.3 Global Ursodeoxycholic Acid API Sales Volume, by Application (%) (2020-2031)
4.4 Global Ursodeoxycholic Acid API Average Price by Application (2020-2031)

5 Segmentation by Region
5.1 Global Ursodeoxycholic Acid API Sales Value by Region
5.1.1 Global Ursodeoxycholic Acid API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ursodeoxycholic Acid API Sales Value by Region (2020-2025)
5.1.3 Global Ursodeoxycholic Acid API Sales Value by Region (2026-2031)
5.1.4 Global Ursodeoxycholic Acid API Sales Value by Region (%), (2020-2031)
5.2 Global Ursodeoxycholic Acid API Sales Volume by Region
5.2.1 Global Ursodeoxycholic Acid API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ursodeoxycholic Acid API Sales Volume by Region (2020-2025)
5.2.3 Global Ursodeoxycholic Acid API Sales Volume by Region (2026-2031)
5.2.4 Global Ursodeoxycholic Acid API Sales Volume by Region (%), (2020-2031)
5.3 Global Ursodeoxycholic Acid API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ursodeoxycholic Acid API Sales Value, 2020-2031
5.4.2 North America Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ursodeoxycholic Acid API Sales Value, 2020-2031
5.5.2 Europe Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ursodeoxycholic Acid API Sales Value, 2020-2031
5.6.2 Asia Pacific Ursodeoxycholic Acid API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ursodeoxycholic Acid API Sales Value, 2020-2031
5.7.2 South America Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ursodeoxycholic Acid API Sales Value, 2020-2031
5.8.2 Middle East & Africa Ursodeoxycholic Acid API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ursodeoxycholic Acid API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ursodeoxycholic Acid API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Ursodeoxycholic Acid API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ursodeoxycholic Acid API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ursodeoxycholic Acid API Sales Value, 2020-2031
6.3.2 United States Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ursodeoxycholic Acid API Sales Value, 2020-2031
6.4.2 Europe Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ursodeoxycholic Acid API Sales Value, 2020-2031
6.5.2 China Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ursodeoxycholic Acid API Sales Value, 2020-2031
6.6.2 Japan Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ursodeoxycholic Acid API Sales Value, 2020-2031
6.7.2 South Korea Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ursodeoxycholic Acid API Sales Value, 2020-2031
6.8.2 Southeast Asia Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ursodeoxycholic Acid API Sales Value, 2020-2031
6.9.2 India Ursodeoxycholic Acid API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ursodeoxycholic Acid API Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 ICE
7.1.1 ICE Company Information
7.1.2 ICE Introduction and Business Overview
7.1.3 ICE Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 ICE Ursodeoxycholic Acid API Product Offerings
7.1.5 ICE Recent Development
7.2 Mitsubishi Tanabe Pharma
7.2.1 Mitsubishi Tanabe Pharma Company Information
7.2.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
7.2.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid API Product Offerings
7.2.5 Mitsubishi Tanabe Pharma Recent Development
7.3 Daewoong Chemical
7.3.1 Daewoong Chemical Company Information
7.3.2 Daewoong Chemical Introduction and Business Overview
7.3.3 Daewoong Chemical Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Daewoong Chemical Ursodeoxycholic Acid API Product Offerings
7.3.5 Daewoong Chemical Recent Development
7.4 PharmaZell GmbH
7.4.1 PharmaZell GmbH Company Information
7.4.2 PharmaZell GmbH Introduction and Business Overview
7.4.3 PharmaZell GmbH Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 PharmaZell GmbH Ursodeoxycholic Acid API Product Offerings
7.4.5 PharmaZell GmbH Recent Development
7.5 Zhongshan Bailing
7.5.1 Zhongshan Bailing Company Information
7.5.2 Zhongshan Bailing Introduction and Business Overview
7.5.3 Zhongshan Bailing Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Zhongshan Bailing Ursodeoxycholic Acid API Product Offerings
7.5.5 Zhongshan Bailing Recent Development
7.6 Dipharma Francis
7.6.1 Dipharma Francis Company Information
7.6.2 Dipharma Francis Introduction and Business Overview
7.6.3 Dipharma Francis Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Dipharma Francis Ursodeoxycholic Acid API Product Offerings
7.6.5 Dipharma Francis Recent Development
7.7 Grindeks
7.7.1 Grindeks Company Information
7.7.2 Grindeks Introduction and Business Overview
7.7.3 Grindeks Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Grindeks Ursodeoxycholic Acid API Product Offerings
7.7.5 Grindeks Recent Development
7.8 Suzhou Tianlv
7.8.1 Suzhou Tianlv Company Information
7.8.2 Suzhou Tianlv Introduction and Business Overview
7.8.3 Suzhou Tianlv Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Suzhou Tianlv Ursodeoxycholic Acid API Product Offerings
7.8.5 Suzhou Tianlv Recent Development
7.9 Yun Gang Bio
7.9.1 Yun Gang Bio Company Information
7.9.2 Yun Gang Bio Introduction and Business Overview
7.9.3 Yun Gang Bio Ursodeoxycholic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Yun Gang Bio Ursodeoxycholic Acid API Product Offerings
7.9.5 Yun Gang Bio Recent Development

8 Industry Chain Analysis
8.1 Ursodeoxycholic Acid API Industrial Chain
8.2 Ursodeoxycholic Acid API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ursodeoxycholic Acid API Sales Model
8.5.2 Sales Channel
8.5.3 Ursodeoxycholic Acid API Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.com
Tel: +91-8669986909
Email- ankit@qyresearch.com

About QY Research Inc.

Founded in 2007 in California, USA, QY Research Inc. is a leading global market research and consulting company with over 18 years of expertise. Specializing in market research reports, custom reports, commissioned research, IPO consultancy, and business plans, QY Research has established offices in seven countries, including the United States, Germany, Switzerland, Japan, Korea, China, and India, with business partners in over 30 countries. To date, the company has provided industrial information services to more than 60,000 companies worldwide.

This release was published on openPR.